Objective: The aim was to update The Endocrine Society Clinical Practice Guideline on
Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published …

Over the last three decades, short-and long-term observational studies, clinical trials,
systematic reviews, and meta-analyses have provided relevant information on the efficacy …

Context In some patients, symptoms may persist after COVID-19, defined as long COVID. Its
pathogenesis is still debated and many hypotheses have been raised. Objective Our primary …

Growth hormone (GH) deficiency is caused by congenital or acquired causes and occurs in
childhood or adulthood. GH replacement therapy brings benefits to body composition …

Since the 1970s, GH treatment has been an important tool in paediatric endocrinology for
the management of growth retardation. It is now accepted that adults with severe GH …

Objective Adults with childhood-onset (CO) craniopharyngioma (COCP) have poor quality of
life (QoL) and clinical outcomes, but few studies have compared these patients with adults …

The GH/IGF1 system, like other endocrine systems, is dynamic and its activity changes with
age and sexual maturation, and is influenced by body composition and other factors. A …

Context: Little is known about the impact of childhood-onset GH deficiency (GHD), in
particular the duration of GH cessation during the transition phase, on adult phenotype …

Previous work has examined potential links between the etiology of GH deficiency (GHD)
and the baseline characteristics of the patients including biochemical and psychometric …

Background Many patients with childhood-onset growth hormone (GH) deficiency do not
fulfill diagnostic criteria for GH deficiency (GHD) after attainment of adult height and may not …